Síndrome colestásico

Flora Zárate Mondragón, Lucía Casas Guzik, Ana Gabriela Ayala Germán

Resumen


La ictericia (coloración amarillenta de la piel y las mucosas), resulta de la acumulación de pigmentos biliares, con concentración de bilirrubina total mayor de 2.5-3 mg/dL.1,2 El síndrome colestásico es la elevación de bilirrubina directa mayor de 1 mg/dL (17 mmol/L), cuando la bilirrubina total es menor de 5 mg/dL o bilirrubina directa mayor de 20%, si la bilirrubina total es mayor de 5 mg/dL.1-3 Cuando persiste más de dos semanas, en los primeros tres meses de vida, se denomina síndrome colestásico neonatal prolongado.3,4


Texto completo:

PDF

Referencias


Andrianov MG, Azzam RK. Cholestasis in infancy. Pediatr Ann. 2016;45(12):e414–9.

Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: Joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2017;64(1):154–68.

Pandita A, Gupta V, Gupta G. Neonatal Cholestasis: A Pandora’s Box. Clinical Medicine Insights: Pediatrics. 2018:12;1-6.

Corcuera CT, Ridaura C, Zárate FE. Atresia biliar perinatal (colangiopatía obliterante inflamatoria progresiva) no corregible tipo III. Acta Pediatr Mex. 2018;39(4):328-37.

Khalaf R, Phen C, Karjoo S, Wilsey M. Cholestasis beyond the neonatal and infancy periods. Pediatr Gastroenterol Hepatol Nutr. 2016;19(1):1–11.

Lane E, Murray KF. Neonatal Cholestasis. Pediatr Clin North Am. 2017; 64(3)621-39.

Feldman AG, Sokol RJ. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol 2019;16(6):346–60.

Ghoshal B, Das A, Mondal T. A Rare Case of Neonatal Cholestasis. J Clin Neonatol 2017;6:34-6.

Girard M, Lacaille F. Diagnosis of Neonatal Cholestasis. Ann Nestlé. 2008;66:109-20.

Matsui A. Screening for biliary atresia. Pediatr Surg Int. 2017;33(12):1305–13.

Reyes A, Flores J, Villasis M, Chávez JA, Delgado EE. Uso de la tarjeta colorimétrica visual para la detección oportuna de atresia de vías biliares. Bol Med Hosp Infant Mex. 2018;75(3):160–5.

Jagadisan B, Srivastava A. Child with Jaundice and Pruritus: How to Evaluate? Indian J Pediatr. 2016;83(11):1311–20

Vázquez R, García JE, Valencia PF, Castro GE, Medina PG, Santillán Y, et al. Mexican consensus on lysosomal acid lipase deficiency diagnosis. Rev Gastroenterol México. 2018;83(1):51–61.

Karpen SJ. Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management. Clin Liver Dis. 2020;15(3):115–19.

Abbey P, Devasenathipathy K, Naranje P. Neonatal Jaundice. Indian J Pediatr. 2019;86: 830-41.

Mitchell E, Gilbert M, Loomes KM. Alagille Syndrome. Clin Liver Dis. 2018;22(4):625–41.

Cho SJ, Kim GE. A practical approach to the pathology of neonatal cholestatic liver disease. Semin Diagn Pathol [Internet]. 2019;36(6):375–88. Available from: https://doi.org/10.1053/j.semdp.2019.07.004

Ridaura C. La biopsia hepática. Acta Pediatr Mex. 2008;29(4):216–26.

Orso G, Mandato C, Veropalumbo C, et al. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. Digestive and Liver Disease. 2016;48:215–22.

Sullivan JS, Mascarenhas MR. Nutrition: Prevention and management of nutritional failure in Cystic Fibrosis. Journal of Cystic Fibrosis. 2017;16:87–93.

Heubi JE, Setchell KDR, Bove KE. Inborn Errors of Bile Acid Metabolism. Clinics in Liver Disease. 2018;22(4):671-87.

Dursun F, Gerenli N, Kirmizibekmez H. Cholestasis and hypercalcemia secondary to panhypopituitarism in a newborn. The Turkish Journal of Pediatrics. 2017;59:100-3.

Whitington PF. Gestational Alloimmune Liver Disease And Neonatal Hemochromatosis. Semin Liver Dis. 2012;32:325–32.




DOI: http://dx.doi.org/10.18233/APM42No5pp260%202672254

Enlaces refback

  • No hay ningún enlace refback.